Simultaneous renal hypertension and type 2 diabetes exacerbate vascular endothelial dysfunction in rats

International Journal of Experimental Pathology

Volumn 93, Issue 3, 2012, Pages 210-217

  Khalili, Azadeh ^a   Nekooeian, Ali Akbar ^a   Khosravi, Mohammad Bagher ^a   Fakher, Shima ^a  

^a Department of Environmental and Radiological Health Sciences   (Iran)

Author keywords

Renal hypertension; Type 2 diabetes; Vascular function

Indexed keywords

ACETYLCHOLINE; GLUCOSE; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HEART RATE; IC 50; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

ACETYLCHOLINE; ANIMALS; AORTA; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GLUCOSE TOLERANCE TEST; HYPERTENSION, RENAL; MALE; MALONDIALDEHYDE; NG-NITROARGININE METHYL ESTER; NITROPRUSSIDE; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 84860999789     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2012.00811.x     Document Type: Article

References (40)

1. Ajay M., Achike F.I., Mustafa M.R. (2007) Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid. Pharmacol. Res. 55, 385-391.
2. Ballo P., Cameli M., Mondillo S. et al. (2010) Impact of diabetes and hypertension on left ventricular longitudinal systolic function. Diabetes Res. Clin. Pract. 90, 209-215.
3. Bauersachs J., Bouloumie A., Mulsch A., Wiemer G., Fleming I., Busse R. (1998) Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc. Res. 37, 772-779.
4. Beenen O.H., Mathy M.J., Pfaffendorf M., van Zwieten P.A. (1996) Vascular responsiveness in isolated perfused kidneys of diabetic hypertensive rats. J. Hypertens. 14, 1125-1130.
5. Cameron N.E. & Cotter M.A. (1992) Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 35, 1011-1019.
6. Campbell K.L., Kushner H., Falkner B. (2004) Obesity and high blood pressure: a clinical phenotype for the insulin resistance syndrome in African Americans. J. Clin. Hypertens. (Greenwich). 6, 364-370; quiz 371-362.
7. Chang H.R., Lee R.P., Wu C.Y., Chen H.I. (2002) Nitric oxide in mesenteric vascular reactivity: a comparison between rats with normotension and hypertension. Clin. Exp. Pharmacol. Physiol. 29, 275-280.
8. Chen G., McAlister F.A., Walker R.L., Hemmelgarn B.R., Campbell N.R.C. (2011) Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure. Hypertension 57, 891-897.
9. Colivicchi F., Mettimano M., Genovesi-Ebert A. et al. (2008) Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications. J. Cardiovasc. Med. (Hagerstown). 9, 267-272.
10. Crabos M., Coste P., Paccalin M. et al. (1997) Reduced basal NO-mediated dilation and decreased endothelial NO-synthase expression in coronary vessels of spontaneously hypertensive rats. J. Mol. Cell. Cardiol. 29, 55-65.
11. Endemann D.H., Pu Q., De Ciuceis C. et al. (2004) Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 43, 399-404.
12. Fischer M., Wiest G., Tekesin I. et al. (1992) Effects of combined renovascular hypertension and diabetes mellitus on myocardial cells, non-vascular interstitium and capillaries: a stereological study on rat hearts. Virchows Arch. A Pathol. Anat. Histopathol. 42, 499-506.
13. Frangioudakis G., Gyte A.C., Loxham S.J., Poucher S.M. (2008) The intravenous glucose tolerance test in cannulated Wistar rats: a robust method for the in vivo assessment of glucose-stimulated insulin secretion. J Pharmacol. Toxicol. Methods 57, 106-113.
14. Friedman J., Peleg E., Kagan T., Shnizer S., Rosenthal T. (2003) Oxidative stress in hypertensive, diabetic, and diabetic hypertensive rats. Am. J. Hypertens. 16, 1049-1052.
15. Gouvea S.A., Bissoli N.S., Moyses M.R., Cicilini M.A., Pires J.G.P., Abreu G.R. (2004) Activity of angiotensin-converting enzyme after treatment with L-arginine in renovascular hypertension. Clin. Exp. Hypertens. 26, 569-579.
16. Hassan Z., Dewa A., Asmawi M.Z., Sattar M.Z.A. (2011) Assessment of vascular reactivity at different time-course on streptozotocin-induced diabetic rats. J. Exp. Integr. Med. 1, 175-183.
17. Hendriks M.G., Kam K.L., Pijl A.J., Pfaffendorf M., van Zwieten P.A. (1993) The effects of hypertension and diabetes mellitus on the vascular reactivity of perfused mesenteric resistance arteries. J. Hypertens. Suppl. 11, S268-S269.
18. Higashi Y., Sasaki S., Nakagawa K., Matsuura H., Oshima T., Chayama K. (2002) Endothelial function and oxidative stress in renovascular hypertension. N. Engl. J. Med. 346, 1954-1962.
19. Howarth F.C., Shafiullah M., Qureshi M.A. (2007) Chronic effects of type 2 diabetes mellitus on cardiac muscle contraction in the Goto-Kakizaki rat. Exp. Physiol. 92, 1029-1036.
20. Howarth F.C., Jacobson M., Qureshi M.A. et al. (2009) Altered gene expression may underlie prolonged duration of the QT interval and ventricular action potential in streptozotocin-induced diabetic rat heart. Mol. Cell. Biochem. 328, 57-65.
21. Indran M., Rokiah P., Chan S.P., Kuppusamy U.R. (2004) Alteration of lipid peroxidation and antioxidant enzymes in young Malaysian IDDM patients. Med. J. Malaysia 59, 166-170.
22. Jadhav G.B. & Upasani C.D. (2011) Effect of silymarin on DOCA salt streptozotocin induced diabetic hypertension in unilateral nephrectomized rats. Int. J. Pharmaceutical. Res. 3, 27-32.
23. Mall G., Klingel K., Baust H. et al. (1987) Synergistic effects of diabetes mellitus and renovascular hypertension on the rat heart--stereological investigations on papillary muscles. Virchows Arch. A Pathol. Anat. Histopathol. 411, 531-542.
24. Masiello P., Broca C., Gross R. et al. (1998) Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47, 224-229.
25. Matsumoto T., Wakabayashi K., Kobayashi T., Kamata K. (2004) Alterations in vascular endothelial function in the aorta and mesenteric artery in type II diabetic rats. Can. J. Physiol. Pharmacol. 82, 175-182.
26. Matsumoto T., Kakami M., Noguchi E., Kobayashi T., Kamata K. (2007) Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 293, H1480-H1490.
27. Muharis S.P., Top A.G., Murugan D., Mustafa M.R. (2010) Palm oil tocotrienol fractions restore endothelium dependent relaxation in aortic rings of streptozotocin-induced diabetic and spontaneously hypertensive rats. Nutr. Res. 30, 209-216.
28. Nekooeian A. & Mashhoodi T. (2007) Solid plexiglass clips to induce reproducible renal hypertension in the rat. Indian J. Pharmacol. 39, 25-26.
29. Ohtomo S., Nangaku M., Izuhara Y., Takizawa S., Strihou C.Y., Miyata T. (2008) Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model. Nephrol. Dial. Transplant. 23, 1166-1172.
30. Pacher P., Liaudet L., Bai P., Virag L., Mabley J.G., Hasko G., Szabo C. (2002) Activation of poly (ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J. Pharmacol. Exp. Ther. 300, 862-867.
31. Sato Y., Iwase M., Wakisaka M. et al. (1995) Renoprotective effect of enalapril in uninephrectomized spontaneously hypertensive rats with neonatal streptozotocin-induced diabetes. Diabetes Res. Clin. Pract. 29, 153-161.
32. Schafer A., Alp N.J., Cai S. et al. (2004) Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo. Arterioscler. Thromb. Vasc. Biol. 24, 1720-1726.
33. Schäfer A., Widder J., Eigenthaler M., Ertl G., Bauersachs J. (2004) Reduced basal nitric oxide bioavailability and platelet activation in young spontaneously hypertensive rats. Biochem. Pharmacol. 67, 2273-2279.
34. Shirwaikar A., Rajendran K., Barik R. (2006) Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocin-nicotinamide induced type-II diabetes mellitus. J. Ethnopharmacol. 107, 285-290.
35. Singhania N., Puri D., Madhu S.V., Sharma S.B. (2008) Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy. QJM 101, 449-455.
36. Souza H.C., Martins-Pinge M.C., Dias da Silva V.J. et al. (2008) Heart rate and arterial pressure variability in the experimental renovascular hypertension model in rats. Auton. Neurosci. 139, 38-45.
37. Taylor P.D., Oon B.B., Thomas C.R., Poston L. (1994) Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 111, 35-41.
38. Wheal A.J. & Randall M.D. (2009) Effects of hypertension on vasorelaxation to endocannabinoids in vitro. Eur. J. Pharmacol. 603, 79-85.
39. Wong C.M., Yao X., Au C.L. et al. (2006) Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats. Vascul. Pharmacol. 44, 290-298.
40. Woodman R.J., Playford D.A., Watts G.F. (2006) Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol. Diabetes Res. Clin. Pract. 71, 59-67.